EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT
Akil Merchant(University of Southern California), Parkash S. Gill(University of Southern California)
Cited by 24
Related Papers
Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma
|Cancer Discovery|2019|226
Receptor Tyrosine Kinase EphB4 Is a Survival Factor in Breast Cancer
|American Journal Of Pathology|2006|190